Variant report
Variant | nsv824652 |
---|---|
Chromosome Location | chr8:58351753-58352791 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM110B-11 | chr8:58352607-58353048 | l_3603_chr8:58348578-58353048_testes |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544355354 | chr8:58351799-58351800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186787927 | chr8:58351800-58351801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9643499 | chr8:58351810-58351811 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs572808996 | chr8:58351855-58351856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9643500 | chr8:58351881-58351882 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs564509374 | chr8:58351889-58351890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530727524 | chr8:58351956-58351957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550493426 | chr8:58352001-58352002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7837934 | chr8:58352032-58352033 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs190308228 | chr8:58352088-58352089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112835790 | chr8:58352104-58352105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535075004 | chr8:58352106-58352107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551822612 | chr8:58352113-58352114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571635183 | chr8:58352114-58352115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537427257 | chr8:58352115-58352116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557682837 | chr8:58352163-58352164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10608038 | chr8:58352193-58352194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547255602 | chr8:58352194-58352195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10090339 | chr8:58352253-58352254 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs117107001 | chr8:58352288-58352289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199931844 | chr8:58352306-58352307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs60664715 | chr8:58352307-58352308 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs72065972 | chr8:58352309-58352310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71517995 | chr8:58352310-58352311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10608039 | chr8:58352312-58352313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112670958 | chr8:58352328-58352329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572623985 | chr8:58352345-58352346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576195734 | chr8:58352441-58352442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs56798085 | chr8:58352443-58352444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11782562 | chr8:58352470-58352471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181331713 | chr8:58352471-58352472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185414504 | chr8:58352510-58352511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375365202 | chr8:58352521-58352522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574919310 | chr8:58352631-58352632 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs6995173 | chr8:58352632-58352633 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs28538457 | chr8:58352734-58352735 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:58350400-58352400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr8:58351000-58352200 | Enhancers | Liver | Liver |
3 | chr8:58351800-58353000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
4 | chr8:58352400-58352800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |